The aortic ring model has become one of the most widely used methods to study angiogenesis and its mechanisms. Many 
Introduction
Angiogenesis, the growth of new blood vessels, plays a critical role in the progression of many diseases [32, 63] 
. Studies conducted during the past four decades have identified key mechanisms of the angiogenic process, leading to the development of potent anti-angiogenic drugs. This field has come of age with the recognition of anti-angiogenic therapy as a new modality to treat
cancer and wet age related macular degeneration of the retina [61] . Instrumental in the attainment of this milestone have been the many experimental models developed to study the mechanisms of the angiogenic process and test the efficacy of antiangiogenic drugs [14] . In vivo models such as the corneal micropocket and the chorioallantoic membrane of the chick embryo have provided invaluable information on the growth of blood vessels in the complex setting of the live animal [179, 194] . In vitro models with isolated endothelial cells have enabled investigators to further analyse mechanisms of angiogenesis in the simplified environment of the culture dish [77] .
One of the most commonly used assays of angiogenesis is the aortic ring model. This model is based on the capacity of rat or mouse aortic explants to form new vessels in gels of collagen, fibrin or basement membrane [11] . [170] . Leighton ( Fig. 1 [213] . [133] . Leighton himself had observed capillary sprouting from different tissue explants but had never published these observations. He had long been interested in the mechanisms by which tumour aggregates replicate and spread, and suspected that the tumour stroma was involved in this process [127, 128] . My request to work in a vascular biology project rekindled Leighton's 
The angiogenic outgrowth produced by the aortic rings consists of a mixed population of native cells that interact through paracrine mechanisms under chemically defined culture conditions. As such the aortic ring model bridges the gap between in vivo and in vitro models of angiogenesis, combining advantages of both systems. The purpose of this paper is to review the literature on this unique model and illustrate how the use of aortic cultures has contributed to our current understanding of the angiogenic process and the development of novel anti-angiogenic drugs.

Early history of the aortic ring model
The original observation that aortic rings have the capacity to produce microvessels in vitro dates back to the early 1980s when I was working in the research laboratory of Joseph Leighton at the Medical College of Pennsylvania in Philadelphia
), whose primary interest was cancer, was attempting to reproduce in vitro physiological gradients of oxygen and nutrient diffusion and had developed ingenious models for the threedimensional growth of cancer cells. I was interested in the biology of blood vessels, a passion I had developed in medical school while working with an animal model of arterial injury and repair
Intrigued by my fondness for endothelial cells, Leighton introduced me to the old tissue culture literature that described formation of capillaries in vitro. As I reviewed these pioneering papers, I learned that Warren Lewis in the 1930s had carefully documented formation of blood vessels in plasma clot cultures of chick embryo skin explants
interest in this area, and led to our first project in the field of angiogenesis.
Among the tissues potentially capable of an angiogenic response we chose the rat aorta which Leighton had already cultured in the past, without ever characterizing the nature of its outgrowth. To my great excitement, rings of rat aorta embedded in plasma clot and cultured in medium supplemented with foetal bovine serum generated a florid angiogenic response [170] . This model proved to be ideal to study the influence of the fibrovascular stroma on the growth and spread of cancer cells. [62] , was beginning to take hold and an increasing number of investigators were joining this field. Folkman's group successfully isolated microvascular endothelial cells from bovine adrenal glands and demonstrated that these cells were capable of forming capillary tubes in vitro [64] . Shortly thereafter, Shing, Folkman and Klagsbrun reported the isolation and purification of the first tumour angiogenic factor from a chondrosarcoma [209] . This molecule turned out to be basic fibroblast growth factor (bFGF) which Denis Gospodarowicz had purified earlier from the bovine pituitary gland [78] . Thus, the birth of the aortic ring model occurred at a very propitious time when the angiogenesis field was entering the age of molecular biology and new discoveries were creating a need for assays that could characterize the activity, potency and mechanism of action of angiogenic regulators.
In the meantime Judah Folkman's hypothesis that tumour growth is angiogenesis dependent, originally formulated in 1971
Morphology of the angiogenic response
We originally cultured aortic rings in plasma clots with serumsupplemented growth medium [170] . Clots were obtained by mixing the supernatant of homogenized chick embryos with a chick plasma solution. In later studies we grew aortic rings under serum-free conditions in gels of purified bovine or human fibrin or rat interstitial collagen [34, 70, 168, 174] . The elimination of serum reduced the number of non-endothelial mesenchymal cells, greatly facilitating the observation and measurement of the angiogenic outgrowths [168] . The development of a whole mount staining method further simplified the morphological analysis of the cultures, obviating the need for the labour-intensive techniques initially used to prepare histological sections [245] . The [73] . Endothelial cell proliferation is critical for optimal angiogenic responses but not necessary for minimal sprouting which can occur exclusively through endothelial migration when cultures are treated with mitomycin C, an inhibitor of cell mitosis [162, 170] . As the outgrowth expands and matures, vessels develop a visible lumen [168, 170] . Over time neovessels become surrounded by pericytes, which migrate and proliferate along the endothelium. Pericytes are readily recognized by their dendritic morphology and close association with the endothelium [174] (Fig. 2) .
Neovessels express the endothelial markers von Willebrand factor (vWF), CD31 and Tie2 [169, 245] , bind the Griffonia Simplicifolia isolectin-B4 [245] , and take up DiI-acetylated LDL [208] . Pericytes are specifically highlighted by immunostaining the cultures for ␣-smooth muscle actin (␣-SMA), desmin, calponin or the proteoglycan NG2 [98, 168, 245] . Fibroblasts stain for vimentin, which is also expressed in pericytes and endothelial cells [34] . Some fibroblasts also express ␣-SMA (myofibroblasts). Macrophages react for CD45, CD68 and CD163 [12, 70] . Dendritic cells stain for CD45 and CD54 (ICAM) (Fig. 2) .
Electron microscopy shows that immature sprouts are composed of solid endothelial cords. Primitive lumens formed through an intercellular mechanism appear as slit-like spaces sealed by junctional complexes. Lumens also develop by coalescence of cytoplasmic vacuoles in adjacent endothelial cells [168, 170] . Endothelial cells rest on a thin basement membrane which is best visible in serum-supplemented cultures [170] [241] . [164] . Using a similar approach Mori et al. noticed that aortic endothelial sprouting occurred at sites of intimal injury [152] . We later observed that isolated rat aortic endothelial cells formed capillary networks when cultured between two layers of collagen, as reported for microvascular endothelial cells [151] , and sprouted following stimulation with angiogenic factors [175] [47, 168] . Vascular outgrowths might have also originated from endothelial progenitor cells, as described for the embryonal aorta [6] . Although we found no evidence of these cells in the adult aorta [98] [8, 224] . A process comparable to non-sprouting angiogenesis occurs at the root of the angiogenic outgrowths where the aortic intimal endothelium reorganizes into vascular channels following exposure of its apical surface to collagen [164] . [188] .
Source of microvessels in aortic cultures
Stimulatory effect of angiogenesis on cancer spread
Regulation of angiogenesis by the extracellular matrix
Our observation that the microvascular extracellular matrix (ECM) was involved in the spread of cancer cells was made at a time when ECM molecules were found to be key regulators of endothelial cell behaviour and capillary morphogenesis [66] . Intrigued by the adhesive properties of the endothelial ECM [172] [166] . Treatment with ascorbic acid enhanced the synthesis and perivascular accumulation of collagen. Microvessels formed in the absence of ascorbic acid became markedly dilated, whereas microvessels treated with ascorbic acid remained small throughout the angiogenic process [160] . Inhibition of perivascular collagen accumulation with cishydroxyproline, a proline analogue that interfered with collagen secretion, blocked the angiogenic response. This effect was reversed by supplementing the cultures with L-proline, which restored endogenous collagen synthesis and secretion [160] . [26, 162, 163] . Fibronectin-treated microvessels grew longer through an increased migratory recruitment of endothelial cells. This effect did not require cell proliferation because it occurred also in cultures treated with mitomycin C, an inhibitor of cell mitosis [162] . Our results were consistent with earlier studies indicating that fibronectin promoted endothelial cell migration [7, 144] and that endothelial cell proliferation was not required for in vivo angiogenic sprouting [212] .
In addition to promoting vascular elongation, type IV collagen and the laminin-entactin complex had a bimodal effect on vascular proliferation. Intermediate concentrations of these molecules stimulated angiogenesis whereas low concentrations were ineffective and high concentrations were anti-angiogenic [26, 163] . In keeping with these observations Kleinman's group later identified 13 synthetic laminin peptides with pro-angiogenic effects in the aortic ring model [140] . Others demonstrated that oncothain, a peptide from the NC1 domain of type IV collagen inhibited aortic angiogenesis, probably through adhesive mechanisms [207] .
The few vessels that formed in aortic cultures supplemented with high doses of type IV collagen or laminin-entactin were highly stable and survived longer than control microvessels [26, 163] 
Role of integrin receptors in aortic angiogenesis
In 1987, Ruoslahti and Piershbacher identified the arginine-glycine-aspartic acid (RGD) amino acid sequence as the cell attachment domain of fibronectin [199] . The RGD motif was also found to mediate cell adhesion to vitronectin, fibrinogen and vWF [45] . RGD peptides interfered with cell adhesion by competing with natural RGD-containing molecules for cell receptor binding, causing detachment of endothelial cells [36] . Because sprouting endothelial cells produced RGD containing molecules [162] , we hypothesized that angiogenesis could be an RGD-dependent process. Treatment of collagen gel cultures with a GRGDS peptide potently inhibited angiogenesis, whereas no effect was obtained with a GRGES control peptide. The effect of GRGDS was nontoxic and reversible because the angiogenic response of the aortic rings was restored following withdrawal of the drug [161] . The GRGDS peptide also induced vascular regression when added to the cultures after the angiogenic growth phase [162] [39, 139, 193] . ␤3 integrins, however, were found to participate in angiogenesis under selected culture conditions. We observed that antibody blockade of both ␤1 and ␤3 integrins was needed to effectively inhibit aortic angiogenesis and promote vascular regression when aortic rings were embedded in fibrin gels [34] . Using a >600 fold higher concentration of anti-␤3 integrin antibody (20 mg/ml) than the one tested in our study (30 [192, 193] [191] .
. Stimulation of VEGFR2 expression and angiogenesis was recently obtained also by treating VEGF-stimulated aortic cultures with low (nanomolar) concentrations of synthetic ␣V␤3/␣V␤5 inhibitors
A number of studies have attempted to identify the ␣ partners of the ␤ integrin receptors involved in aortic angiogenesis. Suda et [225] . Similarly Sassoli and coworkers obtained inhibition of angiogenesis in bFGF-and VEGF-stimulated collagen cultures with specific anti-␣V␤3 and anti-␣V␤5 antibodies [201] . These results suggest that bFGF and VEGF, which up-regulate expression of ␣V␤3 and ␣V␤5 integrins [51, 67] , caused aortic microvessels to become dependent on these integrin subtypes [67] .
Studies with isolated cells showed that the laminin integrins ␣3␤1 and ␣6 ␤1 promoted basement membrane assembly, pericyte association and tube stabilization [43] whereas the integrin ␣6␤4 was involved in angiogenic sprouting [177] . These integrins closely associate with CD151, a tetraspanin family member that modulates endothelial cell spreading, migration and sprouting [93] . The angiogenic response of aortic rings from CD151 null mice in Matrigel was reduced by ~50%. These changes correlated with significant defects in endothelial cell migration, spreading, sprouting and signalling, particularly on a laminin substrate [222] .
Paracrine regulation of angiogenesis: role of endogenous growth factors
My first experiments with the aortic ring model [170, 171] had shown that the aortic wall produced neovessels in response to injury. The presence of serum in the growth medium was however a confounding variable to the analysis of this phenomenon. The same consideration applied to the plasma clot which we were using as a substrate for angiogenic sprouting [170, 171] . We serendipitously overcame this limitation in a collaborative project with George Tuszynski, who was studying the cancer promoting properties of thrombospondin-1 (TSP-1), a platelet-derived protein [228] . Tuszynski [168] . Similar observations were independently made by Kawasaki et al. [112] . Using the serum-free aortic ring assay we demonstrated that TSP-1 had the capacity to stimulate angiogenesis when bound to the ECM, and that this effect was mediated by myofibroblasts [173] .
The discovery that the injured aortic wall produced vessels in the absence exogenous growth factors set us on a quest for the endogenous regulators of this process. In 1987 Gospodarowicz' group had reported that endothelial cells expressed bFGF, a potent inducer of endothelial cell proliferation and angiogenesis, and proposed that endothelial bFGF could function as an autocrine stimulator of angiogenesis [203] . Artery associated bFGF was also found in smooth muscle cells and macrophages [137, 218] . Because injury was believed to be the main mechanism of bFGF release [41] , we suggested that bFGF was one of the autocrine/paracrine regulators of angiogenesis in our model. Immunochemical studies showed that the aortic wall expressed bFGF and rapidly released it following the injury of the dissection procedure [230] . bFGF-containing aorta conditioned medium and purified bFGF increased both the number and length of microvessels sprouting from the explants (Fig. 3) . The bFGF stimulatory effect was most pronounced during the second week of culture when release of bFGF was minimal. The angiogenic response of aortic rings was reduced by 40% with a neutralizing anti-bFGF antibody [230] . Inhibition of angiogenesis was later obtained also with platelet factor-4 (PF-4) which blocks bFGF binding to endothelial cells [84] .
While we were studying mechanisms of angiogenesis in the aortic ring model, three groups independently identified a novel endothelial growth factor in both neoplastic and normal cells [40, 131, 204] . This molecule originally described as a vascular permeability factor by Harold Dvorak and collaborators was later found by Napoleone Ferrara's group to be a specific angiogenic regulator and termed vascular endothelial growth factor (VEGF) [33, 58, 59] . In our laboratory we found that aortic rings produced the alternatively spliced VEGF isoforms 164 and 188 and expressed the VEGF receptor flk-1 (VEGFR2). Rakic et al. later reported that the angiogenic outgrowths produced primarily VEGF120 whereas aortic explants express VEGF 164 and 120 and to a less extent VEGF188 [189] . Protein levels of VEGF in aorta conditioned medium decreased during the second week of culture when the explants became quiescent and microvessels stopped growing [165] . Exogenous VEGF potently stimulated angiogenesis in aortic cultures (Fig. 3) [165, 167] , whereas an anti-VEGF blocking antibody inhibited angiogenesis by 70% [165] . These experiments established VEGF as a key regulator of angiogenesis in the aortic ring model. [49] . Aortic rings harvested from endothelial NOS (eNOS) deficient mice and cultured in Matrigel exhibited a 44% reduction in angiogenesis and a 68% reduction in DNA synthesis compared to control explants [125] . Expression of VEGF was found to be regulated also by prostaglandin E2 (PGE2) [20] which is angiogenic in vivo [65] . As a result, aortic rings from mice deficient in EP2, one of PGE2 receptors, produced fewer vessels than control aortas [110] .
Subsequent studies showed that VEGF production in cells of the vessel wall was stimulated by nitric oxide donors and suppressed by nitric oxide synthase (NOS) inhibitors
Aortic cultures also produced PDGF, a potent mural cell mitogen and chemotactic factor [159, 197] which Risau and collaborators had found to be angiogenic as well [195] . In the aortic ring model endogenous PDGF was required for pericyte recruitment (see below) but not for endothelial sprouting [57, 159] . Exogenous PDGF molecules however dose dependently potentiated the angiogenic response of the aortic rings. PDGF-BB was as effective as VEGF and more potent than PDGF-AA, as reported earlier by Risau and collaborators [167, 195] (Fig. 4) [79, 122, 200] . SDF-1 also promoted the spontaneous angiogenic response of aortic rings in collagen gel culture [200] .
We observed that quiescent aortic rings produced neovessels in response to VEGF but lost their ability to respond to the cytokine/chemokine cocktail that was instead angiogenic in cultures of freshly cut explants [70] . This change in angiogenic behaviour correlated with depletion of adventitial macrophages, and near complete loss of endogenous VEGF production in response to the cytokines/chemokines [70] . To investigate the angiogenic role of resident macrophages, we treated prior to the assay freshly cut aortic rings with liposomal clodronate, a compound that is toxic to phagocytic cells [229] . Selective killing of macrophages markedly impaired the angiogenic response of the aortic rings and their ability to produce VEGF. A comparable effect was obtained by ablating macrophages with diphtheria toxin in aortic cultures from CD11bDTR transgenic mice [31] . Angiogenic sprouting and VEGF production were restored by co-culturing macrophage-depleted rings with exogenous macrophages of bone marrow origin [70] .
Further studies with immunosuppressive compounds corroborated the hypothesis that endogenous stimulation of angiogenesis in the aortic ring model was regulated by the immune system. Aortic angiogenesis was inhibited with hydrocortisone [168] , a commonly used anti-inflammatory drug, TGF␤1 [155, 167] , an inhibitor of the immune system [37, 237] and deactivator of macrophage function [227] , and rmob-1, the rat homologue of the human chemokine interferon ␥ inducible protein 10, IP-10, which inhibits bone marrow colony formation and angiogenesis [1, 9, 215] [146] .
. Angiogenic sprouting in aortic cultures was also blocked with IL-4 and IL-13 [70], both of which inhibit the proinflammatory response of macrophages [88] and with adenoviral vectors carrying the IL-4 or IL-13 genes [82, 83]. Pre-treating the aortic explants with macrophage colony stimulating factor (M-CSF/CSF-1) prior to preparation of the rings promoted angiogenesis whereas treatment with anti-CSF1 antibody significantly impaired the angiogenic response [70]. More recently we found that granulocyte macrophage colony stimulating factor (GM-CSF) stimulates the angiogenic response of the aortic rings (unpublished observations). Others reported that MCP-1, a potent monocyte/ macrophage chemokine, promoted aortic angiogenesis while an anti-MCP1 antibody or a synthetic peptide that blocked MCP1 binding to its receptor CCR2 abrogated the MCP-1 effect [115]. Recently McGonigle and coworkers reported that osteprotegerin (OPG), a soluble TNF receptor family molecule involved in skeletal and immune system function and development [17, 107], stimulated aortic angiogenesis in collagen culture, and found that this effect was blocked by pre-incubating OPG with its ligands receptor activator of NF-B ligand (RANKL) and TNF-related apoptosis inducing ligand (TRAIL). They also observed that RANKL but not TRAIL potently inhibited basal and VEGF-stimulated angiogenesis. OPG promoted endothelial proliferation whereas RANKL had antiproliferative and pro-apoptotic effects
Expression and function of neural related genes
Studies conducted during the past decade showed that developing nerves and blood vessels share molecular mechanisms of cellular path finding and morphogenesis [154, 205] Our microarray studies showed that aortic rings up-regulate numerous neural related genes prior to angiogenesis [12] . Michael Klagsbrun's group found that semaphorin 3A, also known [147] . Studies from other laboratories implicated the Slit/Roundabout (Robo) system in angiogenesis [68, 126] [216] . [120, 141] . [2, 130, 132] . DCC receptors mediate attractive signals whereas repulsive signals are regulated by UNC5-DCC receptor heterodimers or UNC5 dimers [56, 92, 113] 
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Fig. 4 Standard and modified aortic ring model of angiogenesis with quiescent aortic rings. Freshly cut rings of rat aorta embedded in collagen gel generate outgrowths of branching microvessels. Aortic rings lose their spontaneous angioformative properties and become angiogenically quiescent if kept in serum-free growth medium for ~2 weeks prior to collagen embedding. The medium is changed three times a week during this time to deplete the cultures of endogenous growth factors. Quiescent aortic rings remain viable and produce an angiogenic response comparable to that of freshly cut rings when they are re-injured or treated with exogenous angiogenic factors. as collapsin-1, competed with VEGF for binding to neuropilin-1 (NRP1) a VEGFR2 coreceptor, and acting through NRP1 inhibited the motility of endothelial cells, as previously reported for neuronal axons. Using the aortic ring assay they demonstrated that semaphorin 3A blocked endothelial sprouting by 80-90%
Studies with genetically modified mice showed that Ephrins and their Eph receptors regulated angiogenesis in different systems [3, 71, 234]. Ephrins are cell membrane-bound ligands which signal through Eph receptors at sites of cell-cell interactions. Ephrins and Eph receptors are divided into two classes, A and B. Ephrins A bind to Eph A receptors while Ephrins B bind to Eph B receptors, but there is significant promiscuity of receptorligand interactions within each class [69]. Blockade of Ephrin A signalling with soluble EphA2 receptor (EphA2-Fc) dose dependently inhibited angiogenesis in aortic cultures [48]. Simultaneous treatment with EphA2-Fc and the VEGFR2 inhibitor CEP-5214 had additive effects resulting in 90-95% inhibition of aortic angiogenesis. Conversely treatment with EphrinB1-Fc or Ephrin B2-Fc promoted the angiogenic response of the aortic rings
Neural development is regulated by netrins, bifunctional proteins capable of attracting or repelling axons. The netrin effects are mediated by receptors of the DCC and uncoordinated 5 (UNC5) families. DCC receptors include DCC and Neogenin whereas the UNC5 family comprises four members UNC5A to UNC5D
. Using transgenic mice expressing LacZ under the control of the UNC5b promoter, Lerrivee and coworkers identified expression of UNC5b in sprouting microvessels. When they subjected collagen cultures of mouse aorta to gradients of netrin-1 they observed filopodial retraction in endothelial sprouts from UNC5B
ϩ/ϩ and UNC5b ϩ/-aortas but not in sprouts from UNC5b -/-aortas [124] . Conversely Nguyen and [145, 247] [116] . [165, 230] . Because bFGF can induce secretion of VEGF [19] , its rapid release from pre-existing aortic depots after injury [230] [198] . They also found that simultaneous inhibition of both VEGFR and EphA2 pathways caused near complete inhibition of angiogenesis [48] . Anti-angiogenic effects were obtained with JNJ-17029259, a tyrosine kinase inhibitor that blocked VEGFR2 phosphorylation and MAPK signalling [53] . Furthermore transduction of aortic rings with an adenovirus carrying HCPTPA, a tyrosine phosphatase that binds to VEGFR2, caused inhibition of angiogenesis due to impairment of VEGF-mediated VEGFR2 autophosphorylation and MAPK activation [100] . Aortic angiogenesis was also blocked by AZM475271 a src kinase inhibitor required for the phosphorylation of Net [239] and the transduction of VEGF signals [52, 104, 186] .
Cai reported that aortic discs embedded in fibrin produced more vessels when treated with netrin-1 and that this effect was abrogated with an anti-DCC antibody [157]. Although it remains unclear if netrin-1 is pro-or anti-angiogenic, these studies suggest that netrins and their receptors are potential regulators of aortic angiogenesis. Neuropeptide Y (NPY), a sympathetic vasoconstrictor molecule released during nerve activation and ischemia, stimulated endothelial migration, proliferation and angiogenesis by activating receptors Y1, Y2 and Y5
Signal transduction pathways
Our studies implicated bFGF and VEGF as key regulators of angiogenesis in aortic cultures
may be one of the earliest events responsible for the induction of VEGF production and angiogenesis in aortic cultures. Support to this hypothesis was provided by a study on the angiogenic role of Net (Elk-3/Sap-2/ERP), a transcription factor that is converted from a negative to a positive regulator through phosphorylation by Ras, Src and MAPK signalling. bFGF-induced endothelial sprouting was severely impaired in aortic cultures from Net deficient mice. This defect was corrected with exogenous VEGF, suggesting that impaired production of VEGF was responsible for the decreased sprouting [239]. Zhu et al. found that bFGF and VEGF production could be induced by H-2g, a glucose analogue of blood group antigen H [240], through the NF-B pathway. H-2g-mediated stimulation of aortic angiogenesis in Matrigel cultures was inhibited by AG490, a JAK2 inhibitor and LY294002, a PI3 kinase inhibitor. Similar effects were obtained with antisense oligonucleotides (ODN) against these signalling molecules. The angiogenic effect of H-2g was also abrogated by treating the cultures with a decoy NF-B ODN but not with a scrambled control ODN. Studies aimed at developing synthetic inhibitors of VEGFR tyrosine kinases for therapeutic applications further implicated VEGF in the angiogenic response of the aortic rings. Wood and coworkers obtained dose-dependent inhibition of aortic angiogenesis in fibrin gel culture with the VEGFR2 inhibitor PTK787/ZK 222584 [235]. Ruggeri and collaborators observed that the VEGF-R2 signalling inhibitor CEP-5214 (20 nm) significantly reduced the sprouting of aortic rings in collagen gels
In [27] . These findings correlated with decreased in vivo neovascularization in Rap1b-deficient mice and suggested that VEGF and bFGF signalling in the aortic ring model was regulated by Rap1b [38] . [98] .
Pericyte origin and recruitment mechanisms
The possibility offered by the aortic ring model to directly visualize pericytes in the living cultures prompted us to study the molecular mechanisms of pericyte recruitment (Fig. 5 ). We were able to reduce the number of pericytes with a neutralizing antibody against PDGF-B, which mediates pericyte recruitment during embryonal and postnatal angiogenesis [21, 72] , by neutralizing angiopoietin function with Tie2-Fc [106] , by blocking the p38 MAPK pathway [242] and by treating the cultures with heparin [174] . Conversely, we observed increased pericyte numbers in cultures treated with Ang-1 or Ang-2 [106] or with an adenoviral vector carrying the MMK6 gene, an upstream activator of p38 MAPK [242] . We observed an increased recruitment of pericytes also in aortic cultures treated with MCP-1 [10] an Ang-1-induced chemokine [12] . Paik et al. observed that siRNA-mediated knock down of N-cadherin, a cell adhesion molecule involved in endothelial-pericyte interactions markedly reduced the pericyte coating of microvessels in aortic cultures and suppressed the mural cell stimulatory effect of sphingosine-1-phosphate, a platelet-derived mediator of mural cell recruitment [183] . [16, 30, 89, 241] . When we first cultured aortic rings in fibrin gels under serum-free conditions, we observed that endothelial sprouting was precluded by rapid (overnight) and extensive lysis of the fibrin. Blocking fibrinolysis with the serine protease inhibitor -aminocaproic acid preserved the fibrin scaffold and allowed endothelial cells to sprout freely into the fibrin gel [168] . Consistent with this observation, Devy and collaborators observed that aortic rings from plasminogen deficient mice maintained their capacity to sprout, though angiogenesis in these cultures was delayed [39, 46] . Likewise single deficiency of tissue type PA activator (tPA), uPA or uPAR, as well as combined deficiencies of uPA and tPA, did not significantly affect the angiogenic response of aortic explants [46, 95] . However, up-regulated expression of uPA through adenoviral transduction markedly inhibited microvessel growth [143] . [46] . [39] . Studies from our laboratory and by others demonstrated that collagen lysis in aortic cultures was mediated by MMPs. The most abundant MMPs found in aortic cultures were MMP-2 and MMP-9. MMP-2 was abundantly secreted in the culture medium whereas MMP-9 was predominantly found in the gel and specifically in sprouting microvessels [89, 142, 241] . Aortic cultures also produced MMP-3, MMP-10, MMP-11, MMP-13 and MT1-MMP (MMP-14) [30] .Treatment with the broad spectrum MMP inhibitors BB-94 (batimastat), BB-2516 (matimastat) or GM6001 blocked the angiogenic response of the aortic rings in collagen gel cultures [39, 241] . However, the angiogenic response of aortic rings was not affected by isolated or combined genetic disruption of MMP-2 or MMP-9 [13, 39, 142] . Similarly, aortic explants from mice deficient in CD44, an MMP-9 cell surface partner, retained their ability to sprout [96] .
Role of proteolytic enzymes in angiogenesis and vascular regression
Aortic ring cultures produce a broad spectrum of matrix proteinases and inhibitors of proteolysis including plasminogen activators (PA), MMPs, PA inhibitor (PAI-1) and tissue inhibitors of MMPs (TIMPs)
Defective angiogenesis was also observed in cultures of aortic rings from mice lacking PA inhibitor-1 (PAI-1). This angiogenic defect could be reversed by adding recombinant PAI-1 to the culture medium or by transducing the explants with an adenovirus carrying the PAI-1 gene. Exogenous PAI-1 added to cultures of PAI-1 deficient aortic rings was stimulatory at low concentrations (Ͻ100 ng/ml) and inhibitory when used at higher dose (Ͼ1000 ng/ml). Transduction studies with specific mutants showed that PAI-1 promotes angiogenesis through its anti-proteolytic activity and not through its ability to interact with vitronectin
Aortic rings cultured in collagen gel lysed the matrix over time. Using antibodies against a specific fragment of cleaved type I collagen or denatured collagen Stephen Weiss' group identified collagen degradation products in the ECM of neovessel sprouts
Weiss and coworkers demonstrated that that cellular invasion of collagen matrices required membrane type (MT) MMPs, which focus lytic activity to the invadopdia of migrating cells [236] , and not soluble MMPs [96] . Disruption of the MT1-MMP gene caused complete abrogation of aortic angiogenesis in collagen [39] . [75] . A similar effect was obtained by transducing aortic rings with a retrovirus carrying the TIMP-2 gene [86] . The MT1-MMP requirement was matrix dependent because MT1-MMP deficient rings sprouted normally in fibrin gel [39] . However, angiogenesis in fibrin was inhibited by TIMP-2 and TIMP-3, which can block other MT-MMPs besides MT1-MMP [97] . In addition aortic rings from TIMP-3 deficient mice had a significantly enhanced angiogenic response in fibrin gels compared with normal aortic rings [108] . One possible explanation for these results is that the expression and requirement of proteolytic enzymes by aortic outgrowths is influenced by the external matrix and/or growth factor milieu in which vessels sprout. Burbridge [208] . In a modified mouse aortic ring assay VEGF-induced angiogenic sprouting was reduced by 40% in aged animals compared to controls [190] . Recently Facchetti et [29] .
Reduction of angiogenesis was also obtained by treating normal aortic rings with TIMP-2, which inhibited MT1-MMP, but not with TIMP-1, a weak inhibitor of MT1-MMP
Limitations of the aortic ring assay
When compared with in vivo models of angiogenesis, the aortic ring assay has no blood flow, a limitation shared with all other in vitro and ex vivo models of angiogenesis. As a result, the role in angiogenesis of haemodynamic factors and mechanochemical forces cannot be studied in this system [210] . Aortic explants contain macrophages and dendritic cells, but lack other immune cell types, which can however be added to the cultures. The same consideration applies to platelets which are major carriers of both angiogenic and anti-angiogenic factors [28, 105] . Manual counts of microvessels is the most rapid method to measure the angiogenic response in the aortic cultures [11, 168] [94, 138, 176] provides the opportunity to bridge this gap and evaluate in a chemically defined culture environment the angiogenic response of arteries and veins to the same angiogenic regulators.
Summary and conclusion
More than a quarter century after we first reported that explants of rat aorta have the capacity to generate vessels ex vivo [170] [28, 70, 168, 174, 231, 232] 
